Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
about
Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Development of enteric-coated ...... lation and process parameters.
@ast
Development of enteric-coated ...... lation and process parameters.
@en
type
label
Development of enteric-coated ...... lation and process parameters.
@ast
Development of enteric-coated ...... lation and process parameters.
@en
prefLabel
Development of enteric-coated ...... lation and process parameters.
@ast
Development of enteric-coated ...... lation and process parameters.
@en
P2093
P1476
Development of enteric-coated ...... ulation and process parameters
@en
P2093
Aswin Dereymaker
Guy Van den Mooter
Hellen K Stulzer
Manoela K Riekes
P356
10.1016/J.IJPHARM.2017.01.053
P407
P577
2017-01-30T00:00:00Z